Medicinal Usage of Cannabis and Cannabinoids

Medicinal Usage of Cannabis and Cannabinoids offers readers a comprehensive reference on the medical usage and symptom relief provided by these compounds in a variety of disorders. With coverage of neurological diseases like Alzheimer's and Parkinson's, and a wide range of other afflictions including depression, anxiety, nausea and cancer, this broad coverage allows readers to learn about symptom control, along with the physiological, psychological and pharmacological effects of these compounds. Unique case reports are provided as well. This volume provides a platform for research on the use of these compounds in improving patient care, brain function and neurological dysfunction.- Summarizes the medicinal usage of cannabis and cannabinoids in a variety of conditions- Contains chapter abstracts, key facts, a dictionary and a summary- Examines symptom control of conditions such as depression, anxiety and sleep- Discusses cannabis usage in Alzheimer's, Parkinson's, Multiple Sclerosis and cancer- Features case reports and chapters on the physiological, psychological and pharmacological effects

PrefaceI. Setting the scene and introductory chapters1. How medical cannabis may influence the future of medicineMartha Rosenthal2. Medical cannabis and cannabinoids: how best to extract components from plant material Roberta Costi3. Medicinal usage of cannabis and its impact on mental health among cancer patients and survivors Nicolas Hernandez Ortega, Ye Chen, Jessica Y. Islam, Diane Rodriguez, Marlene Camacho-Rivera and Denise Christina Vidot4. Cannabis sativa as a traditional phytomedicine: a new narrative covering different countries Md Nasir Ahmed, Tridib Paul, Md. Nur Kabidul Azam, Rownak Jahan and Mohammed Rahmatullah5. Medical use of cannabis in the middle east Bader Hamza Shirah, Mohammed Ahmed and Ruba Saleh6. What medicinal cannabis is used for: a focus on Canada Dean T. Eurich, Cerina Lee and Jason Dyck7. New York perspectives of medical cannabis laboratory analysisLingyun Li, Stacey Chmura, Christopher Judd and Bryan C. Duffy8. Potential roles of epigenetic memory on the quality of clonal cannabis plants: Content and profile of secondary metabolitesMohsen Hesami and Max Jones9. Aberrant use of medicinal cannabis: theoretical and empirical considerations Daniel Feingold10. Profile of older users of medical cannabis and cannabinoidsJoshua Brown11. Use of cannabidiol oil by caregivers: a focus on Alzheimer's diseaseMagdalena Leszko12. Medicinal use of cannabis: adverse events as a balanced perspectiveGiada Crescioli, Valentina Maggini, Fabio Firenzuoli, Alfredo Vannacci and Niccolo LombardiII. Physiological aspects and metabolic aspects13. Physiopathology and use of cannabinoids for fibrotic diseases Carmen del Rio and E. Munoz14. Cannabinoids in inflammation and atherosclerosis Leonor Thomson, Edward Moreira-Bahnson and Bruno Musetti15. Targeting the CB(2) receptors and other endocannabinoid elements to delay disease progression in cardiovascular diseasesShreesh Ojha16. BMI in cannabis users: regulation, mechanisms and public health impact Thomas ClarkIII. Neurological, psychological and behavioural aspects17. Neuroprotection by cannabis related products, cannabidiol and cannabigerol, and associated mechanisms of actionCarolina Echeverry Sr., Jimena Fagetti, Miguel Reyes-Parada and Cecilia Scorza18. Cannabis terpenes as neuroprotective agents: a focus on alpha-bisabololJohn Staton Laws, Srijan Shrestha and Scott D. Smid19. Cannabidiol in medicinal usage of stress: modelling investigations into cocaineM. Julia García-Fuster and Olga Valverde20. Medicinal cannabis and neurocognition impairmentCaroline MacCallum, April Christiansen, Lindsay Lo, Carly Pistawka, Michael Boivin and Melissa Snider-Adler21. Genetic models of audiogenic seizures: what they are and how cannabinoids and Cannabis-derived compounds can be used to alleviate their symptoms - an updated narrativeNorberto Garcia-Cairasco22. Addressing the validity of cannabinoid therapy as an option for the treatment of substance use disorderRose Chesworth, Erin McLemon and Tim KarlIV. Pharmacological and cellular aspects23. Cannabidiolic acid (CBDA), features and profiles: anti-hyperalgesic effects G. Singh, Katja Linher-Melville and Raphael Mechoulam24. Cannabis-drug interactions: implications for medicinal cannabis use Fran Gengo, Anna Mattle and Christopher Ralyea25. Cannabinoid receptor subtype 2 (CB2R): features and targets for medical applications Marialessandra Contino, Carmen Abate, Nicola Antonio Colabufo, Francesco Leonetti and Angela Stefanachi26. Medical use of cannabidiol and impact on cancer cell viability Kent E. Chair and Wesley Raup-Konsavage27. Anti-inflammatory and antioxidant and immunomodulatory effects of phytocannabinoid ß-caryophyllene: A mechanistic overviewVafa Baradaran Rahimi, Arghavan Memarzia and Prof. Vahid Reza AskariV. Symptom Control and Medicinal Uses28. Cancer patients and providers: Attitudes and beliefs of cannabis and cannabinoids use as a treatment Kimberson Tanco29.